Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Clayton, NC NAICS: 325412
U.S. Department of Labor's OFLC discloses 18 Labor Condition Application filings naming Novo Nordisk Pharmaceutical Industries, LP from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 4 H-1B petitions naming Novo Nordisk Pharmaceutical Industries, LP through FY2024, and approved nearly every one of them: 100% approved (4 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Novo Nordisk Pharmaceutical Industries, LP is listed in 18 DOL LCA filings, more filings than 90% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $123,452. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Clayton, NC.
Novo Nordisk Pharmaceutical Industries, LP vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
18 12320th of 122824 higher than 110,504 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $82,000–$162,707 .
DOL LCA release change
On 18 LCAs with comparable offered vs prevailing wages, Novo Nordisk Pharmaceutical Industries, LP averages about 14.5% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (61.1% of LCA filings).
Certification Rate
100%
Very high DOL cert
Avg. Salary
$123,452
Near portal avg
Total Workers
18
Small worker count
Compensation range for H-1B positions at Novo Nordisk Pharmaceutical Industries, LP
Wage vs. DOL Minimum
+14.5%
At/above DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
61.1% of LCA filings
Full-Time Positions
100%
Primary Worksite County
JOHNSTON, NC
61.1% of LCA filings
Most frequently listed job titles at Novo Nordisk Pharmaceutical Industries, LP
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| QA Area Specialist IV | 3 | $126,694 |
| Validation Area Specialist III - Virginia | 2 | $125,000 |
| Validation Area Specialist - Site Capacity | 1 | $108,000 |
| Validation Area Specialist | 1 | $108,000 |
| Technical Specialist | 1 | $145,000 |
| Supply Chain Engineer | 1 | $135,000 |
| Sr Business Finance Advisor | 1 | $119,068 |
| Quality Control Analyst II OFP | 1 | $82,000 |
| Project Procurement Analyst | 1 | $88,528 |
| Project Manager I - Product & Optimization Projects | 1 | $135,150 |
| Process Technical Analyst | 1 | $96,022 |
| Process Engineer III- Fermentation | 1 | $132,578 |
| Principal Specialist - API | 1 | $162,707 |
| Manager, Facilities Engineering - OFP | 1 | $152,000 |
| Associate Manager, Quality Control Chemistry | 1 | $128,000 |
Cross-state DOL neighbors for Novo Nordisk Pharmaceutical Industries, LP - LCA filing-count and offered-wage axes, outside NC.
Nearest cross-state employer filers by LCA filing count (18 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($123,452 here).
Novo Nordisk Pharmaceutical Industries, LP is listed in 18 DOL Labor Condition Application filings covering 18 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Novo Nordisk Pharmaceutical Industries, LP ranks #11818 by total LCA filing count (18 filings). 110,504 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Novo Nordisk Pharmaceutical Industries, LP has a 100% DOL certification rate, with 18 out of 18 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Novo Nordisk Pharmaceutical Industries, LP's LCAs is $123,452. Listed wages range from $82,000 to $162,707 and are not verified actual compensation.
The top job titles in Novo Nordisk Pharmaceutical Industries, LP's LCA filing records include QA Area Specialist IV, Validation Area Specialist III - Virginia, Validation Area Specialist - Site Capacity. The most common listed title is QA Area Specialist IV with 3 LCA filings at an average listed offered wage of $126,694. This does not establish actual job openings, hiring, or approved petitions.
Novo Nordisk Pharmaceutical Industries, LP is headquartered in Clayton, NC. Their H-1B workers are distributed across 2 states, with the most positions in NC, VA.
No, Novo Nordisk Pharmaceutical Industries, LP is not classified as H-1B dependent.
Novo Nordisk Pharmaceutical Industries, LP is listed in 3 LCA filings in FY2023 and 4 in FY2026. The average listed offered wage increased from $120,341 to $127,521. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-PAR.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Novo Nordisk Pharmaceutical Industries, LP); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PAR.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Novo Nordisk Pharmaceutical Industries, LP); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PAR.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Novo Nordisk Pharmaceutical Industries, LP); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PAR.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Novo Nordisk Pharmaceutical Industries, LP); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PAR.
NC pole at 13,804 LCAs stamps MEGA-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from Novo Nordisk Pharmaceutical Industries, LP's MICRO-BOOK.
Open the NC state board after the ABS peers. Novo Nordisk Pharmaceutical Industries, LP stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Novo Nordisk Pharmaceutical Industries, LP's WAGE-PAR · MICRO-BOOK stamps sit mid-band. Wage levels I-IV explain the floor behind the offer.
What to do with this profile
Use the DOL LCA record for Novo Nordisk Pharmaceutical Industries, LP to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.